ExodusPoint Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

ExodusPoint Capital Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-19,344	Closed	-$57K	–	2628
2022 Q1	$57K	Buy	19,344 +9,077	+88%	+$31.8K	﹤0.01%	2053
2021 Q4	$49K	Sell	10,267 -3,677	-26%	-$23.7K	﹤0.01%	2035
2021 Q3	$106K	Sell	13,944 -18,600	-57%	-$119K	﹤0.01%	1902
2021 Q2	$243K	Sell	32,544 -77,954	-71%	-$601K	﹤0.01%	1870
2021 Q1	$862K	Buy	110,498 +88,591	+404%	+$886K	0.01%	1007
2020 Q4	$202K	Buy	+21,907	New	+$190K	﹤0.01%	1730

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ExodusPoint Capital Management's SURF Position: Q2 2022 in Review

ExodusPoint Capital Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2022, closing a stake of 19,344 shares — an estimated $57K sold.

ExodusPoint Capital Management first reported a position in SURF in Q4 2020 and held it in 6 quarters. The position peaked at $862K in Q1 2021. 84 funds tracked by Wall St. Rank hold SURF as of Q2 2022.

ExodusPoint Capital Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 19,344 Surface Oncology, Inc. Common Stock shares in Q2 2022, an estimated $57K.
ExodusPoint Capital Management first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
ExodusPoint Capital Management's Surface Oncology, Inc. Common Stock position peaked at $862K in Q1 2021.
84 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.